Louis Gleckel - Jul 1, 2022 Form 4 Insider Report for ProPhase Labs, Inc. (PRPH)

Role
Director
Signature
/s/ Louis Gleckel, MD
Stock symbol
PRPH
Transactions as of
Jul 1, 2022
Transactions value $
$0
Form type
4
Date filed
7/5/2022, 07:51 PM
Previous filing
Jun 10, 2021
Next filing
Jun 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRPH Option (right to buy) Award $0 +40K $0.00 40K Jul 1, 2022 Common Stock 40K $12.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with such option vesting in four equal quarterly installments over one year, with the first quarterly installment to vest on September 30, 2022 and each additional installment to vest quarterly thereafter, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of July 1, 2022.